Clasificar por
Keyphrases
Autoimmune Disease
86%
COVID-19
80%
Autoimmunity
59%
Autoantibodies
43%
Rheumatoid Arthritis
41%
Polyautoimmunity
38%
Post-COVID Syndrome
34%
Convalescent Plasma
30%
Meta-analysis
27%
Systemic Lupus Erythematosus
23%
Colombia
22%
T Cells
19%
Autoimmune Thyroiditis
18%
Systematic Meta-analysis
17%
Latin America (LATAM)
17%
Patients with COVID-19
16%
Systemic Sclerosis
15%
Hospitalized Patients
15%
Severe Coronavirus Disease 2019
14%
Sjgren's Syndrome
14%
Confidence Interval
14%
SARS-CoV-2 Variants
13%
Interleukin-6
13%
Primary Biliary Cholangitis
12%
Environmental Factors
12%
Type 1 Diabetes Mellitus (T1DM)
12%
Colombians
12%
Immune System
12%
Clinical Features
12%
Type I Diabetes
11%
CD4+ T
11%
Type I IFN
11%
Autoinflammatory Conditions
11%
Autoimmune Rheumatic Diseases
11%
Cell Response
11%
Platelet Reactivity
11%
High On-treatment Platelet Reactivity
11%
Next-generation Sequencing
11%
Clopidogrel
11%
Pharmacological Analysis
11%
P110
11%
Disease-based
11%
Molecular Mimicry
10%
Immune Response
10%
Autoimmune Response
10%
Latent Autoimmunity
9%
Immunological Characteristics
9%
Systematic Literature Review
9%
Risk Factors
9%
COVID-19 Vaccination
8%
Genetic Factors
8%
Disease Activity Score 28 (DAS28)
8%
Bystander Activation
8%
New Taxonomy
8%
Disease Onset
8%
SARS-CoV-2 Antibodies
8%
COVID-19 Mortality
8%
Virus
8%
Cluster Analysis
8%
Anti-Ro
7%
CD4+ T Cells
7%
COVID-19 Vaccine
7%
Hospitalization
7%
Autoreactive T Cells
7%
Neutrophil Extracellular Traps
7%
Autoimmune Ecology
7%
Zika Virus Infection
7%
Methotrexate
7%
Phosphoinositide 3-kinase (PI3K)
7%
Vaccination
7%
Age of Onset
6%
Convalescent Plasma Therapy
6%
Mechanism of Action
6%
Closure Time
6%
Inception Cohort
6%
Single nucleotide Polymorphism
6%
Immunological Effects
6%
Clinical Manifestations
6%
Coffee Consumption
6%
Post-COVID-19
6%
Immune Dysregulation
6%
Latin American Patient
6%
Randomized Clinical Trial
6%
Cytokine Production
6%
Minor Salivary Gland Biopsy
6%
Constitutional Symptoms
6%
Viral
6%
Increased Incidence
6%
Cardiovascular Disease
6%
Arthralgia
6%
Odds Ratio
6%
Deceased Patients
6%
RAPID3
5%
CD8+ T Cells
5%
Autoimmune
5%
Metabolomics
5%
Lupus
5%
Cholangiopathy
5%
Productive Infection
5%
Glucose-regulated Protein 78 (GRP78)
5%
Immunology and Microbiology
COVID-19
100%
Autoimmunity
96%
Autoimmune Disease
78%
Inflammatory Arthritis
43%
Autoantibody
42%
Severe Acute Respiratory Syndrome Coronavirus 2
38%
T Cell
28%
Systemic Lupus Erythematosus
27%
Blood Plasma
23%
Autoimmune Thyroiditis
20%
Systemic Scleroderma
18%
T-Helper Cell
18%
Prevalence
17%
Cytokine
14%
Immune System
11%
Autoimmune Rheumatic Disease
11%
Salivary Gland
11%
P110δ
11%
Interleukin 6
10%
Immune Response
10%
Molecular Mimicry
9%
Epitope
9%
Infectious Agent
9%
Immune Tolerance
9%
Thyroid
7%
Inflammation Response
7%
Methotrexate
7%
Ro Antibody
6%
Viral Disease
6%
Primary Biliary Cirrhosis
6%
Neutrophil Extracellular Traps
6%
Cytokine Production
6%
Primary Immunodeficiency
5%
Cytotoxic T-Cell
5%
Viral Envelope
5%
Original Antigenic Sin
5%
Immunology
5%
Rheumatic Polymyalgia
5%
Autoimmune Hepatitis
5%
ELISA
5%
Atherosclerosis
5%
Human Immunodeficiency Virus 1
5%
T Lymphocyte Activation
5%
Immunosenescence
5%
La Antibody
5%
Immunodeficiency
5%
Abatacept
5%
Personal Experience
5%
Human immunodeficiency virus
5%
Hashimoto's Thyroiditis
5%
Zika virus
5%
Arthritis
5%
Immune Dysregulation
5%
Enzyme Active Site
5%
SARS Coronavirus
5%
Adoptive Immunity
5%
Ebola Virus
5%
Virus
5%
Rheumatoid Factor
5%
Regulatory T Cell
5%
B Cell
5%
Peptides
5%
Memory T Cell
5%